Praxis Precision Medicines (NASDAQ: PRAX) said the U.S. Food and Drug Administration granted Breakthrough Therapy Designation (BTD) for elsunersen, an ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA